Julie Ehlers

Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.

A wearable ultrasound patch may detect early breast tumors in patients at high risk of breast cancer, according to researchers.

Adding atezolizumab to standard treatment did not improve PFS in patients with advanced ovarian cancer and BRCA1/2 mutations or HRD.

Routine testing for ESR1 mutations should occur upon recurrence or progression of HR+, HER2- metastatic breast cancer, a guideline suggests.

Belantamab mafodotin has shown clinical activity and a manageable safety profile in a real-world population of patients with relapsed/refractory multiple myeloma.

Study results show a new productivity scale measures the workloads of oncology nurse navigators and assists in increasing their productivity.

A new pain assessment documentation tool is helping nurses in an ambulatory clinic better manage telephone triage in oncology care.

A new pain assessment documentation tool is helping nurses in an ambulatory clinic better manage telephone triage in oncology care.

Adding ipilimumab to treatment with nivolumab does not improve response or survival outcomes in recurrent/metastatic HNSCC, a phase 2 trial suggests.

From 15 to 40 years after diagnosis, pediatric cancer survivors have a roughly 4-fold higher risk of death than the general population, a study suggests.